By Jefferey Jaxen

A lawsuit brought against the U.S. Food and Drug Administration (FDA) by the Public Health and Medical Professionals for Transparency (PHMPT) has just been catapulted to international attention – and for good reason.

The original Freedom of Information Act Request (FOIA) brought by attorney Aaron Siri of Siri Glimstad on behalf of PHMPT sought from the FDA all the data submitted by Pfizer to license its Covid-19 vaccine.  After that FOIA was ignored, a suit was brought to which the parties failed to agree to a mutually acceptable production schedule of the more than 329,000+ pages held by the FDA.

PHMPT wanted FDA’s Pfizer’s data out in the public domain sooner than later…the FDA asked the Court for permission to only be required to produce at a rate of 500 pages per month, which would have taken over 75 years to produce all the documents.

However, in a new court ruling yesterday, The U.S. District Court for the Northern District of Texas Fort Worth Division “has soundly rejected the FDA’s request and ordered the agency to produce all the data at a clip of 55,000 pages per month” writes Siri at his Substack account Injecting Freedom.

Judge Mark T. Pittman order statesThe FDA shall produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.”

Commenting on the federal judge’s recent order, Siri stated:

“This is a great win for transparency and removes one of the strangleholds federal “health” authorities have had on the data needed for independent scientists to offer solutions and address serious issues with the current vaccine program – issues which include waning immunity, variants evading vaccine immunity, and, as the CDC has confirmed, that the vaccines do not prevent transmission.”

While the world now waits for the FDA to drop the first 55,000 documents on March 1, it bears repeating what the agency’s earlier trickle of documents has already revealed. For a full review, see our reporting here at The HighWire covering the data.

The early pages, which can be downloaded here, show that in the 2 ½ months following EUA, Pfizer received a total of 42,086 reports containing 158,893 “events.”  Most of these reports were from the U.S. and disproportionately involved women (29,914 vs. 9,182 provided by men) and those between 31 and 50 years old (13,886 vs 21,325 for all other age groups combined, with another 6,876 whose ages were unknown).  Also, 25,957 of the events were classified as “Nervous system disorders”

There were also 1,223 case outcomes listed as ‘fatal.’

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

The Informed Consent Action Network (ICAN) and REACT 19 held a joint press conference today to reveal a trove of secret recordings and FOIA documents of Peter Marks, the former Director of the Center for Biologics Evaluation and Research. The press conference included ICAN Founder Del Bigtree, Attorney Aaron Siri, and REACT 19’s Brianne Dressen.Continue reading ICAN Releases Recordings of FDA’s Peter Marks; Vaccine Official Dismissed Vaccine Injuries

More news about Coronavirus

Health & Nutrition

American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

A new study in JAMA found that US infants under the age of 1 are 1.78 times more likely to die than OECD countries, which are high-income nations. In addition, the study authors found that children aged 1-19 are 1.8 times more likely to die than children in the other 18 countries. From 2011 toContinue reading American Children Face 80% Higher Death Risk Than Peers in Wealthy Nations, JAMA Study Finds

More news about Health & Nutrition

Vaccines

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Vaccines

Science & Tech

Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

Coinbase CEO Brian Armstrong declared his interest in creating a startup to work on gene-editing embryos, a type of editing that people say will lead to the creation of “designer babies.” CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been used in the medical field to help with certain conditions, and recently, a babyContinue reading Coinbase CEO Brian Armstrong Eyes Embryo-Editing Startup

More news about Science & Tech

Environment

USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

The USDA is going to breed millions of flies, sterilize them with radiation, and send them into Texas and Mexico to prevent a re-emergence of the New World Screwworm(NWS), also known as a flesh-eating maggot. The NWS is endemic to Cuba, the Dominican Republic, and some South American countries, but it was eradicated in theContinue reading USDA to Build Sterile Fly Factory to Stop Flesh-Eating Maggots from Invading U.S.

More news about Environment

Policy

Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

Moderna received full FDA approval for its COVID-19 mRNA vaccine, called SpikeVax, for use in children aged 6 months to 11 years who are considered high risk. Previously, this vaccine was only given an Emergency Use Authorization (EUA) for this age group. In May, the CDC announced a change in its COVID-19 vaccine policy, noContinue reading Moderna’s SpikeVax Gets Full FDA Approval for High-Risk Children Amid Lawsuit Over Vaccine Policy Shift

More news about Policy